<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="31941">Oxaliplatin</z:chebi> is one of the agents used against <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Using <z:chebi fb="77" ids="46793">PEG</z:chebi>-liposome encapsulated <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> may enhance the accumulation of drugs in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells, inducing <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>However, the mechanism of action of <z:chebi fb="77" ids="46793">PEG</z:chebi>-liposome encapsulated <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> remains unclear </plain></SENT>
<SENT sid="3" pm="."><plain>SW480 human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells were treated with empty <z:chebi fb="77" ids="46793">PEG</z:chebi>-liposomes, free <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> or <z:chebi fb="77" ids="46793">PEG</z:chebi>-liposomal <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>Cell cycle and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> were assessed using fluorescence confocal microscopy and terminal deoxynucleotidyl transferase-mediated <z:chebi fb="0" ids="17625">dUTP</z:chebi>-<z:chebi fb="0" ids="31624">fluorescein</z:chebi> nick-end-labeling (TUNEL) </plain></SENT>
<SENT sid="5" pm="."><plain>Western blotting was used to analyze the expression of pro-apoptotic, anti-apoptotic and cyclin proteins </plain></SENT>
<SENT sid="6" pm="."><plain>We found that <z:chebi fb="77" ids="46793">PEG</z:chebi>-liposomal <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> induced a stronger apoptotic response than empty <z:chebi fb="77" ids="46793">PEG</z:chebi>-liposomes or free <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, expression of Cyclin D1 increased, whereas expression of Cyclin A decreased after treatment with <z:chebi fb="77" ids="46793">PEG</z:chebi>-liposomal <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>Furthermore, the cell cycle was arrested in the G1 phase </plain></SENT>
<SENT sid="9" pm="."><plain>The results presented here indicate that <z:chebi fb="77" ids="46793">PEG</z:chebi>-liposome entrapment of <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> enhances the anticancer potency of the chemotherapeutic agent </plain></SENT>
<SENT sid="10" pm="."><plain>The effect of <z:chebi fb="77" ids="46793">PEG</z:chebi>-liposomal <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> on <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of SW480 human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells may be through regulation of expression of Cyclin A or Cyclin D1, as well as pro-apoptotic and anti-apoptotic proteins </plain></SENT>
</text></document>